Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
2
Angelini Ventures, Kurma Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 17, 2025 Increased its share capital $52.9M · BODACC Aug 30, 2024 Increased its share capital $42.6M · BODACC May 7, 2023 Increased its share capital $32.4M · BODACC Jun 12, 2022 Increased its share capital $21.6M · BODACC Mar 24, 2021 Increased its share capital $10.8M · BODACC
Registers and programsofficial lists and records that name the company
Legal entity Argobio SAS its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Therini BioSeries A $39M · 16 mo ago • Founded 2016 • 51-200 employees
Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
ImmunaiSeries B $215M · 4 yr ago • 201-500 employees • 13 roles
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Soricimed51-200 employees
Soricimed Biopharma is a clinical stage drug development company dedicated to novel trageted treatments for cancer.
VitaDAOVenture round $4.1M · 3 yr ago • Founded 2021 • 11-50 employees
VitaDAO is a community-owned collective dedicated to funding and advancing early stage longevity science research that can improve people's…
Scioto Biosciences IncVenture round $1.8M · 8 yr ago • Founded 2017
Scioto Biosciences is a preclinical stage biotech company dedicated to innovative research and discovery in the field of microbiome…
Move into a new build home for just 1% upfront. Live there for five years, then choose to buy it with a 10% discount or move on. Get your…

Overview

Argobio SAS is a newly-created START-UP STUDIO dedicated to novel Therapeutics aiming to nurture and launch at least five breakthrough Biotech companies over the next five years.Argobio will source innovative early-stage projects from renowned European academic research institutions.

People

Thierry Laugel
Directeur de la publication
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data